LaserSight Views Pricing Options As Key To LaserScan Marketing Plan
This article was originally published in The Gray Sheet
Executive Summary
LaserSight is highlighting its flexible payment and pricing scheme for its firm's LaserScan LSX ophthalmic excimer laser system as the firm gears up to compete with market leader Visx, with which it withdrew from patent licensing negotiations on Feb. 1.
You may also be interested in...
Summit's Integrated Wavefront Technology To Break In 2001
Summit Technology, backed by encouraging results from 20 patients treated thus far in an ongoing feasibility trial, is hoping to market a customized refractive laser surgical system integrating the company's CustomCornea wavefront measuring device with its LADARVision system by the end of 2001.
Visx v. Nidek ITC LASIK Ruling May Open Door For Bausch & Lomb, Others
A recent ruling by the International Trade Commission weakens, at least temporarily, the patent position of Visx and co-licensor Summit Technology in the rapidly growing laser-assisted in situ keratomileusis (LASIK) market, and creates an opening for a formidable competitor, Bausch & Lomb, whose Technolas LASIK device awaits FDA approval.
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.